Epidemiological and pharmaco-epidemiological study of hospitalized women: a contribution to clinical pharmaceutical education
Abstract
Even today, little is reported in the scientific literature on the participation of pharmaceutical professionals in clinical practices and hospital routines, especially when it comes to women's health. In this sense, this study aimed to describe the clinical-epidemiological and pharmaco-epidemiological profile of a series of cases of women hospitalized in a referral hospital in northern Paraná. This is a series of clinical cases attended and discussed by the multidisciplinary team in women's health at the University Hospital of the State University of Londrina. Data were collected from medical records and during the multidisciplinary anamnesis from March to July 2021. 444 women were assisted, and 44 women were selected for analysis and discussion. Most were pregnant (77.3%), adults aged between 30 and 39 years, multiparous (94.1%), married (82.0%), unemployed (54.5%), with high school complete (43.2%), overweight or obese (54.5%), with an average of 4 multiple diagnoses, with a predominance of hypertension (31.8%) and diabetes (22.7%), and subject to polypharmacy and possible serious drug interactions (25.0%) involving antidepressant drugs and opioid analgesics. Among the most prescribed drugs in practice are Insulin (86.4%), Dipyrone (84.1%), Metoclopramide (70.5%), and Ferrous Sulfate (63.3%). In general, the importance of pharmaceutical care is concluded for contributing to the prevention and reduction of adverse drug reactions and for the identification of inappropriate combinations of prescribed drugs. Furthermore, multi-professional debates, routine procedures, previous investigations of medical records, and the conduct described in the scientific literature can assist in the teaching-learning process of clinical pharmacists.
Keywords
academic training, high-risk pregnancy, drug interactions, polypharmacy, clinical pharmacy service.
Full Text:
PDF (Português (Brasil))DOI: http://dx.doi.org/10.14450/2318-9312.v34.e4.a2022.pp319-327
Refbacks
Copyright (c) 2022 Kaio Yuri Morimoto, Joice Mara Cruciol
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Infarma - Ciências Farmacêuticas
ISSN - 2318-9312 (Versão eletrônica)
ISSN - 0104-0219 (Versão impressa)
Conselho Federal de Farmácia - CFF
SHIS QI 15 Lote "L" - Lago Sul - Brasília - DF
CEP: 71635-615 - Fone: (61)3878-8751
e-mail:infarma@cff.org.br
Diretoria
Walter da Silva Jorge João, Presidente do Conselho Federal de Farmácia
Lenira da Silva Costa, Vice-Presidente do Conselho Federal de Farmácia
João Samuel de Morais Meira, Tesoureiro do Conselho Federal de Farmácia
Luiz Gustavo de Freitas Pires, Secretário-Geral do Conselho Federal de Farmácia